(02-06-2019, 02:28 PM)jj82284 Wrote:

(02-06-2019, 01:34 PM)wrong_box Wrote: To get it on to the market takes time ancompeting drugy. Once on the market all that's left is producing and shipping the product. All the research and development costs have been made,all regulatory obligations satisfied and all that's left is sales

That's not how it works.  Day one of the market you have to work at repaying all that r & d over time.  It's not a magic wand and the consumer pays for a.) The cost of bringing the drug to market and the additional cost of capital not being invested to create a competing drug.

You're either being dense or obfuscating.  Wrong_box knows how business works, and so do I.  Nothing he said was wrong.  It is reasonable for a new drug to be very expensive when it first enters the market.  There is no reason for that price to increase afterwards.  It should only ever go down until all of the initial investment, plus a reasonable margin, is paid off.  Then and only then there could be small price increases due to the cost of inputs, like labor, or botanicals, or petroleum, changing.  That is not what we see when we look at real drugs made by real companies.  We see unexplained and very high price increases even as everything else we can measure remains constant.  Again, look at Humalog insulin.

---